What I Do and Why: HBV Treatment Strategies for Diverse Patient Populations

Featuring interactive multimedia modules, downloadable slidesets, and expert-authored ClinicalThought commentaries from US and European faculty, this program explores in depth why leading experts make specific HBV management decisions in their own practices and equips learners with key strategies for treating a diverse array of patients.
Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
Program Director
Maria Buti, MD
Anna Christina L. dela Cruz, MD
Steven L. Flamm, MD
person default
Pietro Lampertico, MD, PhD


Deciding which patients with chronic hepatitis B should be treated is not as simple as determining if their ALT and DNA levels fall above guideline thresholds. Here’s my take.

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
Program Director
Released: April 6, 2020

Preventing mother-to-child transmission of HBV infection is critical to ensure the long-term health of the newborn. Here’s how we can prevent infection in infants born to mothers with HBV infection.

Maria Buti, MD Released: April 29, 2020

The early detection of HCC in patients with chronic HBV infection means the difference between curable vs terminal disease. Here is how I ensure I do not miss HCC in my patients.

Steven L. Flamm, MD Released: June 16, 2020

What are the pros and cons of discontinuing oral therapy with nucleos(t)ide analogues in patients with chronic HBV infection? Here’s my take.

person default Pietro Lampertico, MD, PhD Released: July 10, 2020

How do you distinguish between patients who are true inactive carriers and those with immune active HBeAg-negative chronic hepatitis B? Here’s my take.

Anna Christina L. dela Cruz, MD Released: August 18, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?